Ga. Qureshi et Sm. Baig, ROLE OF NEUROTRANSMITTER AMINO-ACIDS IN MULTIPLE-SCLEROSIS IN EXACERBATION, REMISSION AND CHRONIC PROGRESSIVE COURSE, Biogenic amines, 10(1), 1993, pp. 39-48
Free amino acid were evaluated in cerebral spinal fluid (CSF) and plas
ma from the patients with multiple sclerosis (MS) in phase of exacerba
tion, remission and chronic progressive states by high-performance liq
uid chromatography. Significantly low levels of GABA, aspartic acid(AS
P), glutamic acid(GLU) and glycine(GLY), two major inhibitory amino ac
ids were found in CSF from patients with MS as compared to healthy con
trols. Taurine(TAU), another putative inhibitory amino acids was also
low whereas glutamine was higher in CSF of MS patients. In plasma, mos
t of the amino acids were unchanged except levels of aspartic acid (AS
P), citrulline (CIT), valine (VAL) and phenylanaline (PHE) were decrea
sed; whereas increased levels of glutamic acid (GLU) and alanine (ALA)
were found in MS patients. The ratios of CSF/ plasma for amino acid s
howed decreased levels for ASP, asparagine (ASN), GLN, CIT and ARG und
er remission and excerabation in MS patients but no changes were obser
ved under chronic progressive state whereas decreased levels in glycin
e (GLY) and increased levels of TYR, methionine (MET) and lysine (LYS)
were observed in these patients. These results suggest that variation
in the amino acid levels in CSF, plasma and their ratios reflect the
abnormal transport mechanism through blood-brain barrier under MS. The
data accumulated may be a helpful tool to improve our knowledge regar
ding pathological and pathogentic processes developed during the cours
e of MS.